These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27756961)

  • 21. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP; Trimble MR; Deakin JF; Stokes TM; Ashford JJ
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy of obsessive-compulsive disorder.
    Klein DF
    Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report.
    Uzun O
    J Psychopharmacol; 2010 Mar; 24(3):425-7. PubMed ID: 19010977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clomipramine discontinuation-emergent dystonia.
    Duggal HS; Dutta S; Sinha VK
    Aust N Z J Psychiatry; 2001 Oct; 35(5):696. PubMed ID: 11551294
    [No Abstract]   [Full Text] [Related]  

  • 25. Concerns regarding study of obsessive-compulsive disorder in dogs.
    Overall KL
    J Am Vet Med Assoc; 1998 Jul; 213(2):198-9. PubMed ID: 9676584
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.
    Foa EB; Liebowitz MR; Kozak MJ; Davies S; Campeas R; Franklin ME; Huppert JD; Kjernisted K; Rowan V; Schmidt AB; Simpson HB; Tu X
    Am J Psychiatry; 2005 Jan; 162(1):151-61. PubMed ID: 15625214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the optimal approach to the pharmacological management of obsessive-compulsive disorder?
    Ravindran AV
    J Psychiatry Neurosci; 1998 Mar; 23(2):136. PubMed ID: 9549253
    [No Abstract]   [Full Text] [Related]  

  • 28. Nicotine augmentation for refractory obsessive-compulsive disorder. A case report.
    Pasquini M; Garavini A; Biondi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):157-9. PubMed ID: 15610960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obsessive-compulsive disorder with unusual themes.
    Gangdev PS
    S Afr Med J; 1996 Jun; 86(6 Suppl):748, 750. PubMed ID: 9180770
    [No Abstract]   [Full Text] [Related]  

  • 30. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
    Cheung EF
    Aust N Z J Psychiatry; 2001 Oct; 35(5):695-6. PubMed ID: 11551293
    [No Abstract]   [Full Text] [Related]  

  • 31. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment-response by age at onset in obsessive-compulsive disorder.
    Fontenelle LF; do Rosário-Campos MC; Mendlowicz MV; Ferrão YA; Versiani M; Miguel EC
    J Affect Disord; 2004 Dec; 83(2-3):283-4. PubMed ID: 15555726
    [No Abstract]   [Full Text] [Related]  

  • 33. Animal behavior case of the month. Congo African Grey parrot examined because of feather picking and self-injurious behavior.
    Juarbe-Díaz SV
    J Am Vet Med Assoc; 2000 May; 216(10):1562-4. PubMed ID: 10825940
    [No Abstract]   [Full Text] [Related]  

  • 34. The assessment of drugs in obsessional states.
    Philpott R
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):91-5. PubMed ID: 973952
    [No Abstract]   [Full Text] [Related]  

  • 35. Elevated thyroid indices in children and adolescents with obsessive-compulsive disorder: effects of clomipramine treatment.
    McCracken JT; Hanna GL
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):581-7. PubMed ID: 16190790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aquagenic pruritus induced by clomipramine.
    Mendlowicz MV; Lima JL; Fontenelle LF
    Gen Hosp Psychiatry; 2013; 35(5):577.e3-4. PubMed ID: 23477795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine.
    Zerjav-Lacombe S; Dewan V
    Ann Pharmacother; 2001 Feb; 35(2):180-2. PubMed ID: 11215836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalised urticaria in a young woman treated with clomipramine and after ingestion of codfish.
    Gallelli L; De Fazio S; Corace E; De Sarro G; Garcia CS; De Fazio P
    Pharmacopsychiatry; 2006 Jul; 39(4):154-6. PubMed ID: 16871472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are gender differences in antiobsessional response related to different clomipramine metabolism?
    Mundo E; Pirola R; Bellodi L; Smeraldi E; Bareggi SR
    J Clin Psychopharmacol; 2002 Jun; 22(3):341-2. PubMed ID: 12006911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.